OUTCOME OF KIDNEY TRANSPLANTATIONS PERFORMED WITH PREFORMED "NATURAL" DONOR-SPECIFIC ANTIBODIES

被引：0
|
作者：
Sicard, Antoine
Amrouche, Lucile
Suberbielle, Caroline
Delahousse, Michel
Legendre, Christophe
Snanoudj, Renaud
机构：
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [41] EARLY OUTCOME OF SINGLE-KIDNEY TRANSPLANTED PATIENTS WITH PREFORMED CIRCULATING DONOR-SPECIFIC ANTI-HLA ANTIBODIES DETECTED BY SOLIDPHASE ASSAYS
    Navas, Ana
    Molina, Juan
    Aguera, Maria-Luisa
    Jurado, Aurora
    Rodriguez-Benot, Alberto
    Alonso, Corona
    Solana, Rafael
    TRANSPLANT INTERNATIONAL, 2019, 32 : 234 - 234
  • [42] DONOR-SPECIFIC ANTIBODIES IN CHILDREN AFTER KIDNEY TRANSPLANTATION
    Lachova, Jitka
    Slavcev, Antonij
    Fornbaumova, Iva
    Vichova, Petra
    Stolbova, Sarka
    Zieg, Jakub
    Simankova, Nadezda
    Dusek, Jiri
    Vondrak, Karel
    Seeman, Tomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [43] KIDNEY TRANSPLANTATIONWITH DONOR-SPECIFIC ANTIBODIES: A GROWING NEED
    Calatayud Aristoy, Emma
    Kanter, Julia
    Gavela, Eva
    Castro Alonso, Cristina
    Montesa Marin, Maria
    Valero Anton, Alejandro
    Beltran, Sandra
    Sancho Calabuig, Maria Asuncion
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I918 - I919
  • [44] The Clinical Significance of Preformed Anti-HLA-DQ Donor-specific Antibodies on Allograft Outcomes in Kidney Transplantation
    Lee, S.
    Yang, C.
    Chung, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 732 - 732
  • [45] The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation
    Lee, S.
    Yang, C.
    Chung, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 732 - 732
  • [46] Kidney Transplantation with Strong Preformed Donor-Specific Antibodies: Impact of C1q-Binding Ability
    Malheiro, J.
    Tafulo, S.
    Santos, S.
    Costa, M.
    Martins, L.
    Dias, L.
    Henriques, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 706 - 706
  • [47] Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies
    Del Bello, Arnaud
    Thaunat, Olivier
    Le Quintrec, Moglie
    Bestard, Oriol
    Durrbach, Antoine
    Perrin, Peggy
    Gatault, Philippe
    Jambon, Frederic
    Pageaux, Georges-Philippe
    Llado, Laura
    Besch, Camille
    Barbier, Louise
    Neau-Cransac, Martine
    Dumortier, Jerome
    Kamar, Nassim
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (12): : 2202 - 2211
  • [48] THE CLINICAL UTILITY OF PREFORMED C1Q-BINDING DONOR-SPECIFIC HLA ANTIBODIES IN KIDNEY TRANSPLANTATION
    Lee, Sua
    Ko, Eun Jeong
    Chung, Byung Ha
    Yang, Chul Woo
    TRANSPLANTATION, 2020, 104 (09) : S3 - S3
  • [49] USE OF ECULIZUMAB IN A KIDNEY TRANSPALNT RECEPTOR WITH HIGH LEVELS OF DONOR-SPECIFIC ANTI-HLA PREFORMED ANTIBODIES
    Cicora, Federico
    Roberti, Javier
    Mos, Fernando
    Paz, Marta
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2013, 33 (02): : 92 - 96
  • [50] Preformed donor-specific antibodies with a high strength are the best predictor for anti body-mediated kidney rejection
    Riethmueller, S.
    Ferrari, S.
    Ruesi-Elsener, B.
    Mueller, M. K.
    Hadaya, K.
    Laube, G.
    Villard, J.
    Fehr, T.
    SWISS MEDICAL WEEKLY, 2009, 139 (45-46) : 5S - 6S
12345